-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Bioage Labs, Lowers Price Target to $20

Benzinga·11/18/2026 19:20:37
Listen to the news
Citigroup analyst Samantha Semenkow maintains Bioage Labs (NASDAQ:BIOA) with a Buy and lowers the price target from $21 to $20.